International Myeloma Foundation
Understanding Carvykti™
Understanding Carvykti™
Regular price
$0.00 USD
Regular price
$0.00 USD
Sale price
$0.00 USD
Unit price
per
Shipping calculated at checkout.
Couldn't load pickup availability
Carvykti™ (ciltacabtagene autoleucel, or “cilta-cel” for short) is a customized immunotherapy approved by the FDA for the treatment of adult patients with relapsed or refractory myeloma after four or more prior lines of therapy. Carvykti uses a patient’s own T cells, which are collected and genetically modified, then infused back into the patient. Carvykti works by recognizing and binding to BCMA, a protein on myeloma cells, leading to the destruction of BCMA-expressing cells, thereby eliminating the myeloma cells.
-
Shipping Information
FREE SHIPPING for all tip cards and publications.
Shipping times typically take 7-14 business days. Orders totaling up to $49.99 will incur a shipping cost of $5; orders totaling $50 and up will incur a shipping cost of $10.
Currently, the IMF does not provide international shipping via our Shopify store. If you are planning to purchase IMF merchandise or to order free educational publications outside of the U.S. (including U.S. territories), please contact the IMF directly at the imf@myeloma.org or 1-818-487-7455.